Mangoceuticals, Inc. (MGRX)

USD 2.45

(-5.04%)

Market Cap (In USD)

4.88 Million

Revenue (In USD)

731.49 Thousand

Net Income (In USD)

-9.21 Million

Avg. Volume

842.54 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.1-16.8
PE
-
EPS
-
Beta Value
0.0
ISIN
US56270V1061
CUSIP
56270V106
CIK
1938046
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Mr. Jacob D. Cohen
Employee Count
-
Website
https://www.mangorx.com
Ipo Date
2023-03-21
Details
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.